‼️Our @unibirmingham.bsky.social #Adrenal Tumour Masterclass 2026 will take place on 12/09/26. Endorsed by @socendocrinology.bsky.social and accredited 6 RCP CPD points. Topic Secondary #Hypertension & #PrimaryAldosteronism #EndoSky #MedSky Registration & programme birmingham.ac.uk/study/short-co…
Cristina L Ronchi
@cronchi.bsky.social
Clinician scientist, adrenal researcher @UoB_MSS Associate Professor in Endocrine Oncology @qehbham @uhbtrust Consultant Endocrinologist @ENSAT_news President @EndoOncology Associate Editor #MedSky https://sites.google.com/view/birmingham-adrenal-team
Our Birmingham Adrenal Team did a great job representing @unibirmingham.bsky.social @ESEndocrinology #ECE2026 in Prague! Well done everyone 👏 Including international fellows & collaborators #adrenal #teamwork #adrenaldisease #EndoSky #MesSky
Excellent start at Day 1 at @esendocrinology.bsky.social #ECE2026 in beautiful Prague! Nice to see everyone.
‼️ Registrations and abstract submissions for the Annual #ENSAT Scientific Meeting 2026 in Porto are now open. Details & programme at: ensat.org/event/25th-ens… ➡️Select your ticket type ➡️Abstract submission link available after registration - deadline 10/06/26! ➡️Travel grants available
ensat.org
"Adrenal tumour diagnostic pathway: findings from a UK national survey” by Sherwin Criseno et al., the 2nd article published in: Pearls and Pitfalls in Adrenal Malignancies. The survey highlights guideline adherence and variability in multidisciplinary practice. 🔗 doi.org/10.1530/EC-2...
🚨 The #ENSAT is thrilled and honoured to announce the senior speakers for the 1st #Educational Webinar on 27/02/2026 on topic #Genetic Breakthroughs in #AdrenalTumours! 🔔 Registration OPEN for everyone. ℹ️ Programme & registration: ensat.org/event-6456168 #EndoSky #MedSky
🚨 The #ENSAT is pleased to announce the chairs for the 1st Webinar scheduled on 27/02/2026. Topiic will be #Genetic Breakthroughs in #AdrenalTumours. 🔔 Registration now OPEN for everyone. ℹ️ Full programme & registration link: ensat.org/event-6456168 #EndoSky #MedSky
A pleasure and a honour to host past #ENS@T President Prof Guillaume Assie from @hopitalcochin.bsky.social in Paris at @unibirmingham.bsky.social Great opportunity to hear him talking about #genomics 🧬 in #endocrinetumours #adrenaltumours 👏and #networking with our #adrenal team!
🚨 Good news! Registrations are open for our 1st #educational Webinar on latest advances in #genetics of #adrenal #tumours. Expect lectures from excellent international speakers and case presentations from early careers. Programme & links: ensat.org/event-6456168 #EndoSky #MedSky
🎄Another well deserved Christmas dinner for our multidisciplinary @unibirmingham.bsky.social #adrenal team #thaifood #Christmas2025 #ChristmasVibes 🎄#team-building #teamscience #teamwork #EndoSky
‼️Don’t forget to register to @unibirmingham.bsky.social #SIMBA #Adrenal 2026. A great #educational opportunity on #adrenaldiseases. Great national & international experts. Endorsed by @socendocrinology.bsky.social & #ENS@T. #EndoSky #MedSky Programme & registration: sites.google.com/view/simbasi...
The publication of the EndoCompass Research Roadmap marks a major milestone for endocrine science. It was a real community effort, involving: 🧠 228 experts 💡 10 specialist partners 🙋♀️ 8 patient advocacy groups Thank you to everyone who contributed! academic.oup.com/ejendo/issue/193/Supplement_2
Well done visiting fellow Lorenzo Tucci @lrnztx.bsky.social & members of our @unibirmingham.bsky.social & UHB NHS Trust #Adrenal Multidisciplinary Team for publishing this case series of long-#adrenalcancer survivors treated with #mitotane #EndoSky #MedSky onlinelibrary.wiley.com/doi/full/10....
Prolonged Mitotane Administration in Metastatic Adrenocortical Carcinoma With Over a Decade of Survival: A Case Series
Background Reports of long-survival patients (>10 years) with metastatic adrenocortical carcinoma (ACC) and prolonged treatment with mitotane alone (>5 years) are rare. We present four patients trea.....
onlinelibrary.wiley.com
Register now for #ECE2026 📆9-12 May 2026 📍Prague, Czech Republic and save with our Super Early Bird registration fees 👉 ow.ly/FLX850XlBCS
🚨 SAVE THE DATE: the ENS@T Educational Team is pleased to announce the newly established ENS@T Webinars coming in 2026! 1st edition on 27/02/2026 about #Genetic Breakthroughs in #AdrenalTumours. Free registration will open soon only for #ENS@T members. Mark your calendars and stay tuned for details.
Even in specialised centres, cyclic #Cushing's syndrome (cCS) diagnosis and management remain challenging with high rates of spontaneous #adrenal #insufficiency, inappropriate surgeries, and poor outcomes www.thelancet.com/journals/lan... cyclic #Cushing's syndrome #cCS #MedSky #EndoSky
Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study
Even in specialised centres, cCS diagnosis and management remain challenging with high rates of spontaneous adrenal insufficiency, inappropriate surgeries, and poor outcomes. Ectopic cCS showed the mo...
thelancet.com
Where are the biggest gaps in adrenal and cardiovascular endocrinology? The second paper in the EndoCompass Research Roadmap outlines future research priorities. Read the full findings 👉 doi.org/10.1093/ejen...
A great pleasure and honour to represent the @unibirmingham.bsky.social adrenal team and the #ENS@T at the @sociedadseen.bsky.social #SEEN2025 in #Granada and talk about molecular studies in clinical practice for #adrenalcancer #adrenocorticalcarcinoma #adrenalresearch #MedSky #EndoSky
Final call for patients with adrenocortical carcinoma (ACC) to join us tomorrow for this webinar Translations into French, German & Italian available. 📅4 October, 10:00-13:00 CEST Register 👉 ow.ly/ERAh50W6CAy
Great time at #ISP2025 in Montréal representing the #ENSAT community together with many others. Honoured to present our @unibirmingham.bsky.social project on #machinelearning #webapp for prediction of #metastasis in #pheo #PPGL 🙏 to the LOC for organising an amazing event! #EndoSky #MedSky #adrenal
Impressions from the joint final EU Cost Action Harmonisation conference & 24th #ENSAT2025 annual meeting in Belgrade! It has been a great success with 230 participants from all over the world. Huge thanks to LOC chair @ljiljanamarina.bsky.social and team, and all the ENS@T ExCo for excellent job.
Another great day yesterday at the ENS@T annual conference with more talks and posters from our @unibirmingham.bsky.social #Adrenal team #ENSAT2025 👏👏👏 #EndoSky
Excellent representation of our @unibirmingham.bsky.social Adrenal Team at the #adrenalcancer oral session at #ENSAT2025 annual meeting in #Belgrade! Well done everyone 👏👏 #EndoSky
Impression of the amazing final Masterclass of the EU Cost Action Harmonisation and reception today in #Belgrade! Well done to the LOC and the Harmonisation team 👏 #adrenaltumour #networking #education #teamwork
A great start in #Belgrade! Thank you @ljiljanamarina.bsky.social & Antoan Soat for the invitation to give a talk on prognostication of #adrenalcancer the #AdvanceAdrenal national symposium! Looking forward to the last EU Cost Action Harmonisation asterclass starting tomorrow! #EndoSky #MedSky
Patients with adrenocortical carcinoma (ACC), this webinar is for you! Our clinical experts will discuss 'Living with Adrenocortical Carcinoma: Care, Support and What's Ahead'. Translations into French, German and Italian. 📅4 October, 10:00-13:00 CEST Register now for free! 👉 ow.ly/ERAh50W6CAy
Are you a postdoctoral female scientist? You could be awarded a £25,000 flexible grant towards advancing your research through the L’Oréal-UNESCO For #WomenInScience UK and Ireland Young Talent Awards.🔬👩🔬 Apply online👉 ow.ly/INSS50WzRgM The application deadline is Wednesday, 20 August at 23:59pm.📅
The #ENS@T Executive Committee is excited to announce the program of the joint final EU #CostAction Harmonis@tion & 24th ENS@T scientific meeting 3-5 Sep 2025 in #Belgrade available at ensat.org! Thanks to the amazing LOC @ljiljanamarina.bsky.social and team! 👏 #adrenal #adrenaltumours #EndoSky
ENS@T - home
ensat.org
Endocrine complications occur in 40–60% of survivors of cancer and include hypothalamic–pituitary disorders, dysregulation of steroid and peptide hormones, and dysregulation of bone and metabolism www.thelancet.com/journals/lan... #OpenAccess #MedSky #EndoSky #OncSky
Endocrine health in survivors of adult-onset cancer
Long-term survivors of cancer (ie, the patient who is considered cured or for whom the disease is under long-term control and unlikely to recur) are at an increased risk of developing endocrine compli...
thelancet.com